AssayIndex
Reports by quarter

Reports submitted in 2025-Q3 · page 12

Kestrel Bioanalytical began contributing; gradient-length normalisation introduced. Median purity for the quarter is 99.03 % area, n=816. Read the 2025-Q3 state-of-the-index report →

816 records21 pagesmedian on this page 98.73 %updated 30 Jul 2026
ReportCompoundSupplierLotLabQuarterPurity %Water %Recovery %ProvenanceFlagsResult
AX-2025-020576TirzepatideSSASSA-2502-D7226Nordanalyt2025-Q397.207.2195.0Buyer-sourced1MARGINAL
AX-2025-020568RetatrutideSSASSA-2508-N7334Janoshik2025-Q397.874.1398.2Buyer-sourced1MARGINAL
AX-2025-020530SemaglutideSSASSA-2502-U6907Janoshik2025-Q398.175.4091.1Buyer-sourced0PASS
AX-2025-020415LiraglutideMKMMKM-2508-P4928Janoshik2025-Q398.046.65—Buyer-sourced0PASS
AX-2025-020148MOTS-cERPERP-2508-M9453Medutest2025-Q399.252.0797.9Buyer-sourced1FAIL
AX-2025-019726SemaglutideHomopeptideHOMO-2505-V3835Nordanalyt2025-Q398.376.1297.9Buyer-sourced0PASS
AX-2025-019464BPC-157JEEPJEEP-2504-X7849Janoshik2025-Q398.786.59—Buyer-sourced0PASS
AX-2025-018821NAD+FGPFGP-2502-E8063Janoshik2025-Q399.6211.29—Buyer-sourced0FAIL
AX-2025-018754Melanotan IIQSCQSC-2503-D7103Janoshik2025-Q399.936.81—Buyer-sourced0PASS
AX-2025-018587SemaglutideQYBQYB-2505-U5049Janoshik2025-Q398.883.6291.2Buyer-sourced1FAIL
AX-2025-018502MOTS-cWWBWWB-2505-G2801Janoshik2025-Q399.413.65103.8Buyer-sourced0PASS
AX-2025-020894Enclomiphene citrateWXTWXT-2506-V2798Kestrel2025-Q399.344.3392.4Supplier-supplied0FAIL
AX-2025-020869IGF-1 LR3WXTWXT-2508-G2536Janoshik2025-Q396.893.75—Buyer-sourced0PASS
AX-2025-020527SemaglutideSSASSA-2502-U6907VendorInvestigate2025-Q397.745.29102.4Buyer-sourced0PASS
AX-2025-0203625-Amino-1MQMKMMKM-2503-H3929Janoshik2025-Q399.684.85—Buyer-sourced0FAIL
AX-2025-020138MOTS-cERPERP-2508-M9453Janoshik2025-Q398.512.1495.6Buyer-sourced0PASS
AX-2025-019739SemaglutideHomopeptideHOMO-2505-V3835Janoshik2025-Q398.265.86—Buyer-sourced0PASS
AX-2025-019195BPC-157SinoPepSNP-2506-U4547PeptideMeter2025-Q398.985.0693.4Buyer-sourced1MARGINAL
AX-2025-019067OxytocinGSPGSP-2506-D2459Janoshik2025-Q399.234.1191.5Buyer-sourced1MARGINAL
AX-2025-018948RetatrutideASYASY-{CAT}-1860Janoshik2025-Q397.896.0691.3Buyer-sourced0PASS
AX-2025-021075L-Glutathione (reduced)BCHBCH-2508-X4357Medutest2025-Q397.446.63—Buyer-sourced1FAIL
AX-2025-020975PT-141 (Bremelanotide)WXTWXT-2507-R4042Janoshik2025-Q398.884.76—Buyer-sourced0PASS
AX-2025-020873BPC-157WXTWXT-2506-M1881Medutest2025-Q399.093.74103.0Buyer-sourced0PASS
AX-2025-020830PT-141 (Bremelanotide)CPCCPC-2502-X2309Janoshik2025-Q397.734.93—Buyer-sourced0FAIL
AX-2025-020746SemaglutideSGNSGN-2502-F9009Nordanalyt2025-Q399.425.30102.4Buyer-sourced1MARGINAL
AX-2025-020370IpamorelinMKMMKM-2504-N4424Janoshik2025-Q399.115.25—Buyer-sourced0PASS
AX-2025-0203655-Amino-1MQMKMMKM-2503-H3929Kestrel2025-Q399.865.3797.3Buyer-sourced0FAIL
AX-2025-020345BPC-157MKMMKM-2502-T3877PeptideMeter2025-Q398.606.99102.4Buyer-sourced0PASS
AX-2025-019921IpamorelinHJHJ-2504-X6056Medutest2025-Q399.936.2993.6Buyer-sourced1FAIL
AX-2025-019737SemaglutideHomopeptideHOMO-2505-V3835PeptideMeter2025-Q398.616.29—Laboratory-retained0PASS
AX-2025-019618BPC-157TFCTFC-2508-W1453Janoshik2025-Q399.763.4392.8Buyer-sourced0PASS
AX-2025-019463BPC-157JEEPJEEP-2504-X7849PeptideMeter2025-Q398.686.72102.9Buyer-sourced0PASS
AX-2025-021219MK-677 (Ibutamoren mesylate)PPGPPG-2508-N7944Nordanalyt2025-Q399.494.86101.7Buyer-sourced0FAIL
AX-2025-020872IGF-1 LR3WXTWXT-2508-G2536VendorInvestigate2025-Q397.644.1096.0Buyer-sourced0PASS
AX-2025-020843KPVCPCCPC-2502-M2176Janoshik2025-Q398.083.15—Buyer-sourced0FAIL
AX-2025-020828PT-141 (Bremelanotide)CPCCPC-2502-X2309PeptideMeter2025-Q397.765.1390.8Supplier-supplied0FAIL
AX-2025-020572TirzepatideSSASSA-2502-D7226Medutest2025-Q398.556.24—Buyer-sourced1MARGINAL
AX-2025-020116SemaglutideERPERP-2508-S8293Janoshik2025-Q398.983.61103.0Buyer-sourced1MARGINAL
AX-2025-019935SemaglutideHJHJ-2507-Y6433Janoshik2025-Q398.393.41—Buyer-sourced0PASS
AX-2025-021107TirzepatideBCHBCH-2508-A5665Janoshik2025-Q399.115.01106.0Buyer-sourced0PASS